Tonghua Dongbao Pharmaceutical Co., Ltd.

Symbol: 600867.SS

SHH

10.3

CNY

Market price today

  • 18.2244

    P/E Ratio

  • 0.0089

    PEG Ratio

  • 20.25B

    MRK Cap

  • 0.02%

    DIV Yield

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) Financial Statements

On the chart you can see the default numbers in dynamics for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Tonghua Dongbao Pharmaceutical Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

01159.7846.5902
743.7
368
356
336.4
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
18.6
9.5
8.9
28.3
14.3
4.1
19
6.1
9.8
54.1
132.6
161.2
17.1
34.6
0

balance-sheet.row.short-term-investments

055.558.537
150.4
-73
-58.8
-29.7
-14.7
-16.3
-17.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0916.8515.4707.3
623.7
724.2
677.2
605.3
519.3
455.7
480.2
535.1
595.5
712.1
560
618.3
626.4
544.2
515.7
835.4
834.4
969.9
1021.6
850.2
127.5
131.8
0.4
0.2
4.1
5.6
0

balance-sheet.row.inventory

0705.3653.9537.9
537.6
628.8
901
973.9
1047.9
954.8
629.6
343.8
233
197.8
187.4
170.1
145.6
145.5
140.1
139.8
140.6
126.6
95.9
98.5
73
53.4
35.1
23.9
25.3
13.4
0

balance-sheet.row.other-current-assets

034.540.515.2
17.4
205.6
339
324.3
406.9
11.2
0.1
12.5
-84.5
-99.9
-79.2
-113.6
-119.4
-89.2
-77.2
-218.5
-248.9
-310.9
-347.8
-220.4
642.3
664.2
526.3
488
258.1
192.1
205.6

balance-sheet.row.total-current-assets

02816.42056.42162.5
1922.4
1926.6
2273.2
2240
2209.8
1633.9
1311.8
1107.4
868.6
1053.9
731
721.5
671.2
610
587.6
785
740.3
789.7
788.8
734.3
852.6
903.5
694.5
673.4
304.6
245.7
205.6

balance-sheet.row.property-plant-equipment-net

02704.42678.42392.1
2287.6
2111
1959.7
1873.4
1851.4
1586.9
1279.9
1259.7
1233.2
1087.1
1147.9
1180.2
1226.9
1224.2
1099.5
873.7
807.7
732.1
673.1
622.3
515.2
478.9
387
185.3
174.5
75.7
43.5

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
4.8
4.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

01338.31069.1796.6
608.8
472.6
388.6
193.6
198.7
102
81.8
80.9
69.1
69.5
77.8
84.9
93.3
104.3
94.3
23.9
32
31.2
30.6
34.7
33
72.1
73.2
9.1
9.8
5.6
0

balance-sheet.row.goodwill-and-intangible-assets

01338.31069.1796.6
608.8
472.6
388.6
193.6
198.7
102
81.8
80.9
69.1
69.5
77.8
84.9
98.2
109.2
94.3
23.9
32
31.2
30.6
34.7
33
72.1
73.2
9.1
9.8
5.6
0

balance-sheet.row.long-term-investments

0534.2304420.9
311.4
428.8
385
368.3
334.3
195.5
246.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

038.646.242.4
37.7
37.8
36.2
39
44.1
44
35.6
28.4
30.5
21
20.7
20.7
21.6
28.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0339.6596.2705.6
635.3
373.1
420.6
38.4
36.8
225.8
0.5
218
178.8
145.8
209
244.2
153.4
297.5
185.7
202.3
226.2
242.1
76.1
65.2
68.3
42.9
24
7.5
7
0.5
17.4

balance-sheet.row.total-non-current-assets

049554693.94357.6
3880.8
3423.3
3190.1
2512.7
2465.2
2154.3
1644.5
1587
1511.5
1323.4
1455.3
1530
1500.1
1659
1379.5
1099.9
1065.9
1005.4
779.8
722.2
616.5
593.9
484.2
201.9
191.3
81.8
60.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.2
0
0
0

balance-sheet.row.total-assets

07771.46750.36520.1
5803.3
5349.9
5463.3
4752.7
4675
3788.1
2956.2
2694.5
2380.1
2377.3
2186.3
2251.4
2171.3
2269
1967.1
1885
1806.2
1795.1
1568.5
1456.5
1469.1
1497.4
1178.7
875
495.9
327.5
266.5

balance-sheet.row.account-payables

0115.980.975
68.2
69.2
132
61.3
90.5
53.2
52
38.9
30.8
37.8
46.7
40.7
49.5
40.8
43.1
44.4
45.2
40.7
39.7
29.3
28.7
19.9
25
20.5
20.7
13.6
0

balance-sheet.row.short-term-debt

0150-21.1-7.9
-8.2
125
450
0
430
872.8
310
283
79
93
64
223
321.7
324.1
251.7
337.9
271.5
249.2
3.2
3.2
3.4
45.9
23
1.7
7.3
0
0

balance-sheet.row.tax-payables

052.513.2111.6
55.5
50.9
40
34.7
20.4
11.7
15.5
14.9
-5.5
4.3
20.5
4
8
12.2
33.7
27.1
17.8
8.8
13.5
4.6
-1.4
-1.2
3.8
3.8
3.9
5.4
0

balance-sheet.row.long-term-debt-total

002.62.6
2.6
2.6
4
0
60
250
298
256.4
238.8
122
266.6
269.1
269.6
270.1
270.1
48.2
99.5
49.5
49.5
0
0
14.3
15
28.6
11.5
0
0

Deferred Revenue Non Current

027.528.528.7
32.9
33.4
33.7
35
24.2
24.5
24
-211.4
-226.9
-108.9
-252.1
-251.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0243.881.2193.6
140
29.9
69.4
113.7
5.4
2
3.3
16.3
11.8
12.1
9
11.8
6.8
6.5
6.4
2.7
9.4
6.3
3.9
6.5
2.9
0.5
1
0.8
1.1
60.3
23.5

balance-sheet.row.total-non-current-liabilities

07.438.731.3
35.6
36.3
37.7
40.3
90.7
282.4
335.1
303.2
252.9
136
284.6
303.5
312.9
313.4
315.6
94
100.3
50.9
52
1.7
0
14.4
15
28.6
11.5
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0527.6200.7299.9
243.8
341.1
729.1
215.3
729.8
1309.1
795.7
678.2
388.9
299.4
453.7
624.7
737.7
735
691.1
544.2
480.1
393.9
205.5
78
44.1
92.8
249.8
64.7
51.6
73.9
23.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01993.61993.72034
2034
2034
2034
1711.3
1421.9
1135.8
1030.1
931.5
776.2
776.2
575
479.1
368.6
368.6
368.6
324.5
324.5
324.5
324.5
324.5
324.5
324.5
208
208
115.6
92.4
77.8

balance-sheet.row.retained-earnings

03697.43025.52700.5
1951.1
1531.1
1208.4
1130.3
942.3
819.9
686.3
716.5
708.3
808.8
482.7
320.1
252.8
212.2
110.5
100.3
87.6
167.8
138.5
190
234.5
196.6
170
91.9
73.8
5.7
26.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

01003.41188.11039.9
863.5
662.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0516.8336.9440.4
705.5
772.5
1481.9
1686.3
1575
503.6
421.4
343.2
477.2
461
641.9
793.6
772.4
911.2
754
871.4
867.8
865.9
859.1
857.6
859
850.6
524.9
510.5
255
155.5
138.5

balance-sheet.row.total-stockholders-equity

07211.26544.36214.9
5554
5000.4
4724.3
4527.9
3939.2
2459.3
2137.7
1991.2
1961.7
2046
1699.6
1592.9
1393.8
1492
1233.1
1296.1
1279.9
1358.2
1322
1372.1
1417.9
1371.6
902.9
810.3
444.4
253.6
243

balance-sheet.row.total-liabilities-and-stockholders-equity

07771.46750.36520.1
5803.3
5349.9
5463.3
4752.7
4675
3788.1
2956.2
2694.5
2380.1
2377.3
2186.3
2251.4
2171.3
2269
1967.1
1885
1806.2
1795.1
1568.5
1456.5
1469.1
1497.4
1178.7
875
495.9
327.5
266.5

balance-sheet.row.minority-interest

05.15.35.3
5.5
8.4
10
9.6
6
19.7
22.8
25
29.5
31.9
32.9
33.8
39.8
42
42.9
44.6
46.2
43
41
6.5
7.1
33
26
0
0
0
0

balance-sheet.row.total-equity

07216.36549.66220.2
5559.5
5008.8
4734.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0589.8362.5457.9
461.8
355.8
326.2
338.6
319.6
179.2
228.8
213.4
173
138.9
209
244.2
153.4
297.5
162.3
202.3
226.2
242.1
76.1
65.2
63.9
38.4
21.7
0
0
0.5
0

balance-sheet.row.total-debt

01502.62.6
2.6
125
450
0
490
1122.8
608
539.4
317.8
215
330.6
492.1
591.3
594.1
521.8
386.1
371
298.7
52.7
3.2
3.4
60.2
38
30.3
18.9
0
0

balance-sheet.row.net-debt

0-954.2-785.4-862.4
-590.7
-243
94
-336.4
254.4
910.6
406.1
323.3
193.2
-29
267.8
445.4
572.6
584.6
512.9
357.7
356.7
294.6
33.7
-2.9
-6.4
6.1
-94.6
-130.9
1.8
-34.6
0

Cash Flow Statement

The financial landscape of Tonghua Dongbao Pharmaceutical Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

01167.81581.81308.6
930.3
809.6
838.9
840.1
639.2
490.1
276.5
179.5
59.6
363
173.4
67.7
44.6
75.7
13.3
18
-74.8
38.2
44.4
31
48
71.5
90.7

cash-flows.row.depreciation-and-amortization

0207.1151.2143.7
154.5
152.8
172
166.5
160.4
130.8
112.8
108.3
107.6
106.7
103.5
89
72.8
69
64
57.9
48.9
46.9
37.9
27.1
26.5
30.9
17.2

cash-flows.row.deferred-income-tax

07.53.7-4.7
0.2
-1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-863.734.147.7
3.5
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-449.572.6-48.4
82.7
96.8
-34.7
-65
-140.3
-332
-228.2
-88.5
-59
-156.9
3.6
-33.1
-62.8
-1.1
68
1.8
-62.9
-44.5
-41.7
59.3
-46.3
-197.8
-314.4

cash-flows.row.account-receivables

0-430.9140.6-97.7
2.3
-43.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-55.5-124.7-3.4
97.3
269.7
73.7
71.9
-99.4
-330.1
-287
-110.4
-28.6
-3.3
-17.3
-31.5
-0.1
-5.4
-0.3
0.8
-14
-30.7
2.6
-25.5
-24.7
-18.3
-11.1

cash-flows.row.account-payables

03752.957.5
-17.1
-128.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

003.7-4.7
0.2
-1.3
-108.4
-136.9
-40.9
-2
58.7
21.9
-30.4
-153.6
20.9
-1.6
-62.7
4.2
68.4
1
-48.9
-13.9
-44.3
84.8
-21.7
-179.4
-303.2

cash-flows.row.other-non-cash-items

0815.4-980.3-312.3
21.1
93
-99.2
19.6
66.5
5.7
44.8
21.9
86.1
-367.8
-120.1
42.6
37.7
-22.6
12.7
14.5
102
4.9
-8.6
0.3
0.9
0.2
-10.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-348.1-491.6-600.7
-479.6
-293.1
-773.1
-185.5
-411.5
-400.1
-106.1
-190.4
-241.8
-88.8
-72.7
-79.1
-56.7
-258.3
-286.9
-119.4
-49.1
-57.9
-89.4
-88.7
-52.5
-241
-16.5

cash-flows.row.acquisitions-net

00.4020.4
-28.1
0
778.4
0.2
412.1
-0.1
0
0
241.9
0
73.2
19.7
0
0
0
0
0
0
0
0
0
241
0.1

cash-flows.row.purchases-of-investments

0-238.1-1153.5-844.5
-510
-438
-518
-1244
-738.9
-1.8
0
-34.4
-17.2
0
-36.1
79.4
0
0
-9.7
0
-6.9
-161.9
-9.5
0
0
-2.5
-28.9

cash-flows.row.sales-maturities-of-investments

0240.61992.81458.9
399.9
579.1
536
1321.2
312.1
48.7
0
0
14.1
456.2
143.9
51.3
0
84.8
0
0
0
0
0
0
0
0.5
0

cash-flows.row.other-investing-activites

00-3.70
1.2
-0.4
-773.1
1.7
-411.5
-225.2
0
56.4
-241.8
0.1
-72.7
-79.1
0
0
0
0
0
0
0.5
0
-1
-241
4.2

cash-flows.row.net-cash-used-for-investing-activites

0-345.234434.1
-616.6
-152.5
-749.7
-106.5
-837.9
-578.4
-106
-168.3
-244.9
367.4
35.7
-7.7
-56.7
-173.5
-296.6
-119.4
-55.9
-219.8
-98.4
-88.7
-53.5
-242.9
-41.1

cash-flows.row.debt-repayment

0-15000
-400
-851.3
-501.3
-1019.3
-1396.9
-359.3
-362.3
-98.3
-102.3
-171.8
-275.5
-332.5
-324.6
-181.7
-458.4
-195.5
-170.2
-82
-97
-5.5
-20.6
-41.7
-101.4

cash-flows.row.common-stock-issued

00077.4
59.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
-59.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-495.9-1095.8-425
-413.7
-427.4
-355.7
-299.9
-271.8
-247.1
-222.6
-181.2
-169.9
-16.6
-22.5
-32.2
-23.7
-19.2
-16
-18.2
-19.3
-86.7
-1.5
-32.7
-1.1
-4.4
-6.9

cash-flows.row.other-financing-activites

0422-188.3-348
333
324.5
649.3
561
1804.2
900.3
470.9
318.6
204.4
63
118
234.3
321.7
254.1
593.6
254.9
242.5
328
177.9
5.3
3.8
305.6
336.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-224-1284.1-695.6
-480.8
-954.2
-207.7
-758.2
135.5
293.9
-114
39
-67.8
-125.4
-180
-130.4
-26.5
53.2
119.2
41.2
53
159.3
79.5
-32.9
-17.9
259.5
228.6

cash-flows.row.effect-of-forex-changes-on-cash

00.600
0
0
0
0
0
0.3
0
-0.3
-1
-5.7
0
0
-35.6
52.6
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0316.1-77473
94.9
45.5
-80.5
96.5
23.4
10.3
-14.2
91.5
-119.4
181.2
16.1
28.1
-26.5
53.2
-19.4
14
10.2
-14.9
13
-3.9
-42.3
-78.5
-29.5

cash-flows.row.cash-at-end-of-period

01104.2788.1865
392
297.1
251.7
332.1
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
-26.5
53.2
8.9
28.3
14.3
4.1
19
6.1
9.8
54.1
132.6

cash-flows.row.cash-at-beginning-of-period

0788.1865392
297.1
251.7
332.1
235.6
212.2
201.9
216.1
124.6
244
62.8
46.7
18.6
0
0
28.3
14.3
4.1
19
6
10
52.1
132.6
162.1

cash-flows.row.operating-cash-flow

0884.7863.11134.5
1192.3
1152.2
876.9
961.2
725.8
294.6
205.9
221.1
194.3
-55.1
160.4
166.2
92.3
120.9
158
92.2
13.2
45.5
32
117.7
29.1
-95.1
-217

cash-flows.row.capital-expenditure

0-348.1-491.6-600.7
-479.6
-293.1
-773.1
-185.5
-411.5
-400.1
-106.1
-190.4
-241.8
-88.8
-72.7
-79.1
-56.7
-258.3
-286.9
-119.4
-49.1
-57.9
-89.4
-88.7
-52.5
-241
-16.5

cash-flows.row.free-cash-flow

0536.6371.5533.8
712.7
859
103.9
775.7
314.2
-105.5
99.8
30.7
-47.5
-143.9
87.7
87.1
35.6
-137.4
-128.9
-27.2
-35.9
-12.4
-57.4
29
-23.3
-336.1
-233.5

Income Statement Row

Tonghua Dongbao Pharmaceutical Co., Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 600867.SS is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

03061.42778.53267.9
2892.2
2777.1
2692.9
2545.3
2040.4
1669.3
1451.3
1204.2
991.5
784.5
637.8
573.9
551
470
401.6
329.7
307.8
298.7
280.6
205.9
199.1
219.7
218.9
205.4
223.8
212.2
132

income-statement-row.row.cost-of-revenue

0689.7617.5575.7
588.4
721.5
745
644.5
491.9
412.9
452
385.4
357.3
295.4
243.4
245.2
262.2
242.2
217.7
192.3
168.5
151.1
138.1
116.8
103.3
79.8
59.7
57.3
62.8
49.5
0

income-statement-row.row.gross-profit

02371.62160.92692.2
2303.8
2055.6
1947.9
1900.9
1548.5
1256.4
999.3
818.8
634.2
489.1
394.3
328.7
288.9
227.8
184
137.4
139.3
147.6
142.4
89.1
95.8
139.9
159.2
148.1
161
162.7
132

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-5.6145.3171.8
99
121.9
-15.5
-13.2
20.2
1.3
3.1
6.2
18.2
4.1
8.5
27.8
7.3
11.7
3.4
2.8
3.3
1.3
2.4
5.2
11.5
23.9
17.3
0.3
0.9
0.5
0.2

income-statement-row.row.operating-expenses

01101.11270.41420.7
1163.9
1101.4
957.8
897.8
742.2
683.7
635.5
592.6
500.5
434.4
324
232.6
192.2
174.9
124.9
102.4
173.5
106.2
96.1
60.6
51.5
70.2
65.3
50.6
47.5
61.9
0.2

income-statement-row.row.cost-and-expenses

01790.91887.91996.3
1752.2
1822.9
1702.8
1542.3
1234
1096.6
1087.5
978
857.8
729.8
567.4
477.8
454.3
417.1
342.5
294.7
342
257.3
234.3
177.4
154.7
150
125
107.9
110.3
111.4
0.2

income-statement-row.row.interest-income

0-11.713.98.1
4.7
7.2
3.3
1.6
0.8
2.1
0.7
0.8
0.9
0.4
0.1
0.1
0.1
0.1
0.8
2.2
2.4
2.2
1.8
1.4
7.2
0
0
0
0
0
0

income-statement-row.row.interest-expense

04.50.30.2
10.2
20.6
13.5
15.5
44.6
18.2
27.5
17.6
13.8
16.6
22.5
32.2
23.7
19.3
16
16.2
17.4
6
0.7
0.3
0.3
-6.2
-2.4
-7.4
-3.6
-0.3
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

06.20.6-14.8
-72.5
-15.4
-12.6
-30
-47.4
-2.2
-40
-14.5
-66.7
372.2
128.5
-15.7
-31.3
34.1
-40.5
-14.4
-40
1.9
5.8
3
17.5
21.9
28.8
7.2
3.6
-1.5
-59.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-5.6145.3171.8
99
121.9
-15.5
-13.2
20.2
1.3
3.1
6.2
18.2
4.1
8.5
27.8
7.3
11.7
3.4
2.8
3.3
1.3
2.4
5.2
11.5
23.9
17.3
0.3
0.9
0.5
0.2

income-statement-row.row.total-operating-expenses

06.20.6-14.8
-72.5
-15.4
-12.6
-30
-47.4
-2.2
-40
-14.5
-66.7
372.2
128.5
-15.7
-31.3
34.1
-40.5
-14.4
-40
1.9
5.8
3
17.5
21.9
28.8
7.2
3.6
-1.5
-59.7

income-statement-row.row.interest-expense

04.50.30.2
10.2
20.6
13.5
15.5
44.6
18.2
27.5
17.6
13.8
16.6
22.5
32.2
23.7
19.3
16
16.2
17.4
6
0.7
0.3
0.3
-6.2
-2.4
-7.4
-3.6
-0.3
0

income-statement-row.row.depreciation-and-amortization

0207.1156.6156.1
84.9
171.6
172
166.5
160.4
130.8
112.8
108.3
107.6
106.7
103.5
89
72.8
69
64
57.9
48.9
46.9
37.9
27.1
26.5
30.9
17.2
-7.8
-4.6
-2.6
59.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01270.51828.91549.3
1180.7
967.8
993
986.2
738.9
569.2
327.4
206.6
49
423.1
190.4
52.7
58.3
75.5
22.6
22.3
-71.1
45.6
52.6
36.9
55.1
84.5
105.7
105.3
118.1
103.4
72.1

income-statement-row.row.income-before-tax

01276.71829.51534.5
1108.1
952.5
977.5
973
758.9
570.5
323.8
211.8
67.1
426.9
198.9
80.4
65.4
87
22.3
22.8
-70.9
45.1
53.5
36.8
64.2
100
122.8
105.2
118
101.6
72.2

income-statement-row.row.income-tax-expense

0198247.7225.9
177.8
142.9
138.6
132.9
119.7
80.5
47.3
32.3
7.4
63.9
25.5
12.7
20.9
11.4
9
4.8
3.9
6.9
9.2
5.7
16.2
28.4
32.2
14.5
36.5
33.5
23.8

income-statement-row.row.net-income

01167.81581.91308.3
929.9
811.2
838.6
836.6
640.9
493
279.8
183.9
62.7
364
178.4
73.7
46.8
77.4
12.1
16.2
-78.2
36.1
40
29.3
46.3
67.6
92.6
90.6
81.5
68.1
48.4

Frequently Asked Question

What is Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) total assets?

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) total assets is 7771366505.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.796.

What is company free cash flow?

The free cash flow is 0.267.

What is enterprise net profit margin?

The net profit margin is 0.378.

What is firm total revenue?

The total revenue is 0.420.

What is Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) net profit (net income)?

The net profit (net income) is 1167835317.000.

What is firm total debt?

The total debt is 150000000.000.

What is operating expences number?

The operating expences are 1101149964.000.

What is company cash figure?

Enretprise cash is 0.000.